Aave liquidates attacker's rsETH.
Centrifuge launches deSPXA on Base.
Validators consolidate 10m ETH.
ArbitrumDAO rsETH recovery vote.
Aave executed a governance-authorized liquidation of rsETH collateral held by the April 18 KelpDAO attacker across Ethereum mainnet and Arbitrum V3, seizing approximately 89,567 rsETH. A temporary oracle adjustment forced the positions into a liquidatable state, collateral was swept to a recovery guardian multisig, and all configuration changes were fully reverted. No other users were affected. The recovered rsETH is being redeemed for ETH to clear the deficit across affected Aave markets, with full restoration of rsETH backing in its final stages. Read more →
Centrifuge launched deSPXA on Base, a tokenized version of the Anemoy S&P 500 fund managed by Janus Henderson and benchmarked by S&P Dow Jones Indices, bringing 24/7 on-chain exposure to the S&P 500 for eligible non-U.S. users. It is the first product under Centrifuge's deRWA framework, designed to make tokenized real-world assets composable with DeFi protocols. Coinbase named Centrifuge a preferred tokenization infrastructure partner. Read more →
Ethereum validators have consolidated over 10 million ETH, more than a quarter of all staked ETH, using 0x02 withdrawal credentials. Just 1.4% of validators, roughly 12,500 out of 897,000, now control this stake. The consolidation is enabled by MaxEB (EIP-7251), introduced in Pectra, which raised the maximum effective validator balance from 32 ETH to 2,048 ETH. Having fewer validator indices directly improves Ethereum's finality times. Read more →
ArbitrumDAO rsETH recovery vote
L2Beat interop pages
Glamsterdam devnet 3
Ethereum mainnet tx uptrend
PQ tx signature breakout #7
Aave analytics dashboard v2
Katana $100k trading competition
IRIS introduces origination layer
ETHis partners with Use Case Lab
Disclaimer: Content is for informational and educational purposes only and does not constitute financial, investment, legal, or other professional advice. No representations or warranties are made as to accuracy, completeness, or timeliness. Use of this content is at your own risk, and you should consult a qualified professional before making decisions. No fiduciary or advisory relationship is created